share_log

金达威(002626.SZ)：利用合成生物技术已运用在辅酶Q10、NMN、ARA等产品的规模化生产

Jin Dawei (002626.SZ): Using synthetic biotechnology, it has been used in large-scale production of products such as Coenzyme Q10, NMN, ARA, etc.

Gelonghui Finance ·  May 20 04:11

Gelonghui, May 20, 丨 Jin Dawei (002626.SZ) said on the investor interactive platform that the company has used synthetic biotechnology for large-scale production of products such as coenzyme Q10, NMN, NADH, vitamin K2, nattokinase, PQQ, SAMe, DHA, ARA, etc., and also uses synthetic biology to lay out new products, such as astaxanthin, inositol, calcium pantothenate, glutathione, etc. The company will also use synthetic biotechnology to lay out biosubstitutes, such as alloxone sugar, tag sugar, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment